Document is current
Any future updates will be listed below
-
Authors
Riaz, Saman
Steinsland, Hans
Andersen, Ann Z.
Boysen, Anders
Hanevik, Kurt https://orcid.org/0000-0002-1466-2326
-
Funding
Funding for this research was provided by:
Research Council of Norway (234364, 234364, 234364)
Innovation Fund Denmark (7041-00220, 7041-00220)
University of Bergen
- License Information
-
More Information
Article History
Received: 15 July 2024
Accepted: 24 November 2024
First Online: 14 December 2024
Declarations
:
: AB is listed as an inventor on a patent relating to WO 2017/059864 held by the University of Southern Denmark and Aarhus University. AB and AZA have a financial interest in GlyProVac ApS, which has licensed exclusively the IP stated above. AB is the scientific founder and shareholder. AZA is a co-founder, shareholder, and a member of the board. AB and AZA are employees of GlyProVac ApS, and KH is a member of the GlyProVac scientific advisory board. Other authors declare no conflict of interest.
